000			02182 a2200577 4500
005			20250513212413.0
264		0	_c20000629
008			200006s 0 0 eng d
022			_a1523-6838
024	7		_a10.1016/s0272-6386(00)70056-4 _2doi
040			_aNLM _beng _cNLM
100	1		_aKojima, K
245	0	0	_aProtection of alpha(3) integrin-mediated podocyte shape by superoxide dismutase in the puromycin aminonucleoside nephrosis rat. _h[electronic resource]
260			_bAmerican journal of kidney diseases : the official journal of the National Kidney Foundation _cJun 2000
300			_a1175-85 p. _bdigital
500			_aPublication Type: Journal Article
650	0	4	_aAnimals
650	0	4	_aAntibiotics, Antineoplastic _xadverse effects
650	0	4	_aAntigens, CD _xdrug effects
650	0	4	_aCell Adhesion _xdrug effects
650	0	4	_aCell Count _xdrug effects
650	0	4	_aCell Membrane _xmetabolism
650	0	4	_aCell Membrane Permeability _xdrug effects
650	0	4	_aDisease Models, Animal
650	0	4	_aEpithelial Cells _xdrug effects
650	0	4	_aFree Radical Scavengers _xblood
650	0	4	_aHalf-Life
650	0	4	_aHumans
650	0	4	_aIntegrin alpha3
650	0	4	_aIntegrins _xdrug effects
650	0	4	_aKidney Glomerulus _xcytology
650	0	4	_aKidney Tubules _xdrug effects
650	0	4	_aLuminescent Measurements
650	0	4	_aMale
650	0	4	_aMicroscopy, Confocal
650	0	4	_aMicrovilli _xdrug effects
650	0	4	_aNephrosis _xdrug therapy
650	0	4	_aPhosphatidylcholines _xmetabolism
650	0	4	_aProtective Agents _xmetabolism
650	0	4	_aProteinuria _xprevention & control
650	0	4	_aPuromycin Aminonucleoside _xadverse effects
650	0	4	_aRats
650	0	4	_aRats, Wistar
650	0	4	_aReactive Oxygen Species _xmetabolism
650	0	4	_aRecombinant Proteins
650	0	4	_aSuperoxide Dismutase _xblood
700	1		_aMatsui, K
700	1		_aNagase, M
773	0		_tAmerican journal of kidney diseases : the official journal of the National Kidney Foundation _gvol. 35 _gno. 6 _gp. 1175-85
856	4	0	_uhttps://doi.org/10.1016/s0272-6386(00)70056-4 _zAvailable from publisher's website
999			_c10797098 _d10797098